Evaluation of Efficacy and Safety of Oral Solution Resfenol in Reducing Symptoms of Common Cold And Flu
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01158326|
Recruitment Status : Completed
First Posted : July 8, 2010
Last Update Posted : November 28, 2011
This study aimed to evaluate the efficacy and safety of the oral solution of paracetamol, chlorpheniramine maleate and phenylephrine hydrochloride in reducing symptoms of flu and the common cold. There will be a randomized, double-blind, placebo-controlled trial. Will be included 216 subjects, male or female, aged greater than 12 and less than or equal to 60 years, irrespective of color and / or race with symptoms of recent onset, for more than 6 hours and less than 48 hours length, characterizing Common Cold and / or Influenza.
After clinical evaluation and laboratory research subjects will be randomized to receive active drug or placebo, 10 ml oral solution every 6 hours for 48 hours. The follow-up visits will be held on 2 (24 hours after first intervention) and in 3 days (48 hours after first intervention).
The outcomes to assess the effectiveness so far consist of the scores of symptoms and to assess the safety of the drug will be accompanied by the emergence of adverse events.
|Condition or disease||Intervention/treatment||Phase|
|Common Cold Influenza||Drug: Resfenol Other: Placebo||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||216 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Official Title:||Evaluation of Efficacy and Safety of Oral Solution Paracetamol, Maleate Chlorpheniramine and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu: a Double-blind|
|Study Start Date :||August 2010|
|Actual Primary Completion Date :||September 2011|
|Actual Study Completion Date :||November 2011|
Active Comparator: Resfenol Solution oral
Acetaminophen, chlorpheniramine maleate, phenylephrine hydrochloride active drug
Paracetamol (acetaminophen), chlorpheniramine maleate, phenylephrine hydrochloride.
10 ml of oral solution acetaminophen, chlorpheniramine maleate, phenylephrine hydrochloride every 6 hours for 48 hours.
Other Name: Antigripal
Placebo Comparator: Placebo
Placebo oral solution
10 ml of oral placebo every 6 hours for 48 hours
Other Name: Placebo Antigripal
- Reduction global symptom score (0-none, 1-weak, 2-medium, 3-strong) [ Time Frame: 48 hours ]emergence of adverse events
- Use of rescue medication for relief of symptoms, treatment compliance, improvement of foot [ Time Frame: 48 hours ]Subjective evaluation of the research subject and the physician
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01158326
|Hospital de Clinicas de Porto Alegre|
|Porto Alegre, Rio Grande do Sul, Brazil|
|Principal Investigator:||Paulo D Picon, Doctor||Federal University of Health Science of Porto Alegre|
|Study Director:||Luis Felipe C Schmidt, MD||Hospital de Clinicas de Porto Alegre|
|Study Director:||Marisa B Costa, MS||Federal University of Rio Grande do Sul|